Research

Cellular

Metabolic dysfunction associated steatohepatitis (MASH) is a leading cause of chronic liver disease worldwide.

Healthcare providers should recognize MASH as a significant health concern.

StrongSupportsmedium confidence
Metabolic dysfunction associated steatohepatitis (MASH), formerly known as NASH, represents one of the leading causes of chronic liver disease worldwide.
Alessandra Mangia et al. · Liver International · 2025

Why this rating

The claim is based on a broad understanding of MASH's impact on liver disease.

Source

Safety Choice Drivers of the Coming Treatment Options for Non‐Cirrhotic Metabolic Steatohepatitis

Alessandra Mangia et al. · Liver International · 2025

DOI 10.1111/liv.70271

otherCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →